Targeting EZH2 for glioma therapy with a novel nanoparticle–siRNA complex

References

• VerhaakRGHoadleyKAPurdomEIntegrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell20101719811020129251
   PubMed Web of Science ®Google Scholar
• PhillipsHSKharbandaSChenRMolecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesisCancer Cell20069315717316530701
   PubMed Web of Science ®Google Scholar
• MitchellDABatichKAGunnMDTetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patientsNature2015519754336636925762141
   PubMed Web of Science ®Google Scholar
• GersonSLMGMT: its role in cancer aetiology and cancer therapeuticsNat Rev Cancer20044429630715057289
   PubMed Web of Science ®Google Scholar
• KleerCGCaoQVaramballySEZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cellsProc Natl Acad Sci USA200310020116061161114500907
   PubMed Web of Science ®Google Scholar
• NikoloskiGLangemeijerSMKuiperRPSomatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromesNat Genet201042866566720601954
   PubMed Web of Science ®Google Scholar
• XuKWuZJGronerACEZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independentScience201233861131465146923239736
   PubMed Web of Science ®Google Scholar
• KouzaridesTChromatin modifications and their functionCell2007128469370517320507
   PubMed Web of Science ®Google Scholar
• ChangCJYangJYXiaWEZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signalingCancer Cell20111918610021215703
   PubMed Web of Science ®Google Scholar
• LuCHanHDMangalaLSRegulation of tumor angiogenesis by EZH2Cancer Cell201018218519720708159
   PubMed Web of Science ®Google Scholar
• RichterGHPlehmSFasanAEZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiationProc Natl Acad Sci USA2009106135324532919289832
   PubMed Web of Science ®Google Scholar
• CreaFFornaroLBocciGEZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesisCancer Metastasis Rev2012313–475376122711031
   PubMed Web of Science ®Google Scholar
• FillmoreCMXuCDesaiPTEZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitorsNature2015520754623924225629630
   PubMed Web of Science ®Google Scholar
• TachibanaMAmatoPSparmanMTowards germline gene therapy of inherited mitochondrial diseasesNature2013493743462763123103867
   PubMed Web of Science ®Google Scholar
• HeYChengGXieLPolyethyleneimine/DNA polyplexes with reduction-sensitive hyaluronic acid derivatives shielding for targeted gene deliveryBiomaterials20133441235124523127334
   PubMed Web of Science ®Google Scholar
• WangCFLinYXJiangTHeFZhuoRXPolyethylenimine-grafted polycarbonates as biodegradable polycations for gene deliveryBiomaterials200930274824483219539366
   PubMed Web of Science ®Google Scholar
• DaiJZouSPeiYPolyethylenimine-grafted copolymer of poly(l-lysine) and poly(ethylene glycol) for gene deliveryBiomaterials20113261694170521093048
   PubMed Web of Science ®Google Scholar
• MengYWangSLiCPhotothermal combined gene therapy achieved by polyethyleneimine-grafted oxidized mesoporous carbon nanospheresBiomaterials201610013414227258483
   PubMed Web of Science ®Google Scholar
• BaoXWangWWangCA chitosan-graft-PEI-candesartan conjugate for targeted co-delivery of drug and gene in anti-angiogenesis cancer therapyBiomaterials201435298450846624997481
   PubMed Web of Science ®Google Scholar
• SheWLuoKZhangCThe potential of self-assembled, pH-responsive nanoparticles of mPEGylated peptide dendron-doxorubicin conjugates for cancer therapyBiomaterials20133451613162323195490
   PubMedGoogle Scholar
• WilsonWRHayMPTargeting hypoxia in cancer therapyNat Rev Cancer201111639341021606941
   PubMed Web of Science ®Google Scholar
• HuangYGoelSDudaDGFukumuraDJainRKVascular normalization as an emerging strategy to enhance cancer immunotherapyCancer Res201373102943294823440426
   PubMed Web of Science ®Google Scholar
• HillVKRickettsCBiecheIGenome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicityCancer Res20117182988299921363912
   PubMed Web of Science ®Google Scholar
• LiMZhangZLiXWhole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathwayNat Genet201446887287624997986
   PubMed Web of Science ®Google Scholar
• CrowleyEDi NicolantonioFLoupakisFBardelliALiquid biopsy: monitoring cancer-genetics in the bloodNat Rev Clin Oncol201310847248423836314
   PubMed Web of Science ®Google Scholar
• MatsikaASrinivasanBDayCCancer stem cell markers in prostate cancer: an immunohistochemical study of Aldh1, Sox2 and EZH2Pathology201547762262826517640
   PubMedGoogle Scholar
• LiAMDunhamCTaboriUEZH2 expression is a prognostic factor in childhood intracranial ependymoma: a Canadian pediatric brain tumor Consortium studyCancer201512191499150725586788
   PubMed Web of Science ®Google Scholar
• BrackenAPPasiniDCapraMEZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancerEMBO J200322205323533514532106
   PubMed Web of Science ®Google Scholar
• MckinneyEFLyonsPACarrEJA CD8+ T cell transcription signature predicts prognosis in autoimmune diseaseNat Med2010165586591581 following 59120400961
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-AbinaSHauerJLimAEfficacy of gene therapy for X-linked severe combined immunodeficiencyN Engl J Med2010363435536420660403
   PubMed Web of Science ®Google Scholar
• KlatzmannDAbbasAKThe promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseasesNat Rev Immunol201515528329425882245
   PubMed Web of Science ®Google Scholar
• HinrichsCSMolecular pathways: breaking the epithelial cancer barrier for chimeric antigen receptor and T-cell receptor gene therapyClin Cancer Res20162271559156427037253
   PubMed Web of Science ®Google Scholar
• YinHKanastyRLEltoukhyAANon-viral vectors for gene-based therapyNat Rev Genet201415854155525022906
   PubMed Web of Science ®Google Scholar
• SchirrmacherVFournierPNewcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancerMethods Mol Biol200954256560519565923
   PubMedGoogle Scholar
• PaulAHasanAKindiHAInjectable graphene oxide/hydrogel-based angiogenic gene delivery system for vasculogenesis and cardiac repairACS Nano2014888050806224988275
   PubMed Web of Science ®Google Scholar
• NiRZhouJHossainNChauYVirus-inspired nucleic acid delivery system: linking virus and viral mimicryAdv Drug Deliv Rev2016106Pt A32627473931
   PubMedGoogle Scholar
• LeeMSLeeJEByunETarget-specific delivery of siRNA by stabilized calcium phosphate nanoparticles using dopa-hyaluronic acid conjugateJ Control Release201419212213024995950
   PubMed Web of Science ®Google Scholar
• KimHKimWJPhotothermally controlled gene delivery by reduced graphene oxide-polyethylenimine nanocompositeSmall201410111712623696272
   PubMed Web of Science ®Google Scholar
• BryantRJCrossNAEatonCLHamdyFCCunliffeVTEZH2 promotes proliferation and invasiveness of prostate cancer cellsProstate200767554755617252556
   PubMed Web of Science ®Google Scholar